The inverse scattering transform (IST) is developed for a class of matrix nonlinear Schrödinger-type systems whose reductions include two equations that model certain hyperfine spin F = 1 spinor Bose-Einstein condensates, and two novel equations that were recently shown to be integrable, and that have applications in nonlinear optics and four-component fermionic condensates. In addition, the general behavior of the soliton solutions for all four reductions is analyzed in detail, and some novel solutions are presented.
In this work we develop the inverse scattering transform (IST) for the defocusing Ablowitz–Ladik (AL) equation with arbitrarily a large nonzero background at space infinity. The IST was developed in previous works under the assumption that the amplitude of the background Qo satisfies a “small norm” condition 01, and exhibits discrete rogue wave solutions, some of which are regular for all times. Here, we construct the IST for the defocusing AL with Qo>1, analyze the spectrum, and characterize the soliton and rational solutions from a spectral point of view.
We formulate the direct and inverse problems by using a suitable uniformization variable, and pose the inverse problem as an RHP across a simple contour in the complex plane of the uniform variable. As a by‐product of the IST, we also obtain explicit soliton solutions, which are the discrete analog of the celebrated Kuznetsov–Ma, Akhmediev, Peregrine solutions, and which mimic the corresponding solutions for the focusing AL equation. Soliton solutions that are the analog of the dark soliton solutions of the defocusing AL equation in the case 0
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.